SODIUM OXYBATE

all catalysts(0)

nothing on the calendar yet

News(2)

• Takeda leads wave of orexin drugs with potential to upend narcolepsy market
  The FDA’s August approval of Takeda’s Orzeyful for treating the full set of narcolepsy symptoms initiated a new era in the sleep market.
  biospace · 1mo ago
• STAT+: Takeda’s narcolepsy drug approved by the FDA, seen as a boon for new class of treatments
  The FDA approved a novel type of treatment for narcolepsy made by Takeda, backing a new drug class that scientists hope can be used to treat other conditions.
  stat · 1mo ago